Illumina Inc (ILMN)
Receivables turnover
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 4,504,000 | 4,465,000 | 4,461,000 | 4,447,000 | 4,583,000 | 4,699,000 | 4,692,000 | 4,656,000 | 4,526,000 | 4,280,000 | 3,966,000 | 3,473,000 | 3,239,000 | 3,238,000 | 3,351,000 | 3,556,000 | 3,543,000 | 3,458,000 | 3,404,000 | 3,396,000 |
| Receivables | US$ in thousands | 734,000 | 690,000 | 741,000 | — | 671,000 | — | — | — | 648,000 | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | 6.14 | 6.47 | 6.02 | — | 6.83 | — | — | — | 6.98 | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2023 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $4,504,000K ÷ $734,000K
= 6.14
The receivables turnover ratio of Illumina Inc has shown a decreasing trend over the past eight quarters, starting at 7.58 in Q1 2022 and declining to 6.14 in Q4 2023. This indicates that the company is collecting its accounts receivable less frequently over time. A lower receivables turnover ratio may suggest inefficiencies in accounts receivable management or potential issues with customer creditworthiness. It is important for Illumina Inc to monitor this trend and take proactive measures to improve their accounts receivable turnover in order to maintain healthy cash flows and liquidity.
Peer comparison
Dec 31, 2023
Company name
Symbol
Receivables turnover
Illumina Inc
ILMN
6.14
Avantor Inc
AVTR
6.05
Bio-Rad Laboratories Inc
BIO
5.27
Bruker Corporation
BRKR
5.51
Cytek Biosciences Inc
CTKB
3.45
Mettler-Toledo International Inc
MTD
5.71
Revvity Inc.
RVTY
4.38
Waters Corporation
WAT
4.07